Overview
Targeted specifically at summarizing current knowledge of the Abeta peptide and its role in Alzheimer’s disease
Includes supplementary material: sn.pub/extras
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (16 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
Recent advances in genetics and brain biochemistry point to the Abeta peptide as the major culprit in causing neurodegeneration in Alzheimer’s Disease (AD). Abeta Peptide and Alzheimer’s Disease is specifically targeted at summarizing current knowledge of the Abeta peptide and its role in AD.
Written by leaders in the industrial and academic world specializing in this rapidly moving area, the book covers fundamental biochemical studies on this peptide, the genetic impact on Abeta expression and processing, and various AD therapeutic strategies that target Abeta. Although specifically focusing on the Abeta peptide and AD, there is also some discussion on the similarity and differences of this peptide and AD with other amyloidogenic diseases, such as prion disease, Parkinsons and Huntingtons. This book will primarily be of interest to AD researchers and clinicians but also to researchers of other amyloid diseases.
Editors and Affiliations
Bibliographic Information
Book Title: Abeta Peptide and Alzheimer's Disease
Book Subtitle: Celebrating a Century of Research
Editors: Colin J. Barrow, David H. Small
DOI: https://doi.org/10.1007/978-1-84628-440-3
Publisher: Springer London
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag London 2007
Hardcover ISBN: 978-1-85233-961-6Published: 18 December 2006
Softcover ISBN: 978-1-4471-6234-6Published: 20 September 2014
eBook ISBN: 978-1-84628-440-3Published: 22 December 2006
Edition Number: 1
Number of Pages: XI, 298
Topics: Neurology, Neurosurgery, Medical Biochemistry, Neurosciences, Molecular Medicine, Human Genetics